Lowered Return Expectations Among Several Trends Pointing to a Shift in Private Markets Due Diligence says New eVestment Survey
ATLANTA, May 23, 2019 (GLOBE NEWSWIRE) -- Private markets funds have continued to rake in new commitments from institutional investors eager to diversify their portfolios and capture the returns private markets investments can offer. However, investors are now tempering their private markets return expectations. Coupled with other industry trends, this will have implications for private markets fundraising and due diligence according to a new eVestment report, produced in association with parent company Nasdaq.
The 2019 eVestment Private Markets Due Diligence Survey of institutional investors, consultants and private markets fund managers finds that 52% of investors expect returns in the space to decline in the future (page 16). Only 12% of investors expected private equity returns to increase, with the balance – 36% – expecting returns to stay about the same.
Forty-seven percent of investors surveyed expect to see lower returns in venture capital vs. just 16% of investors who expect returns to increase. And in real estate, 41% of investors expect to see lower returns vs. 14% who expect returns to increase.
Another interesting point from the report is the apparent mismatch between fund managers’ desire to find new investors and investors’ desire to reduce or keep stable the number of fund managers with which they work (page 18). In the survey, three out of four fund managers indicated they plan to increase their investor base, while three out of four investors indicated they actually plan to maintain or decrease the number of fund managers with which they work.
“Due diligence remains the foundation for investors looking to build a quality portfolio and generate above market returns,” said Graeme Faulds, Director of Product – Private Markets at eVestment. “With the majority of survey respondents’ outlook for returns to be flat at best, and a desire from investors to consolidate manager relationships, due diligence processes are only going to become more critical for both sides of the table. The need for fund managers and investors to embrace better data and technology to help them navigate this reality has never been more important.”
A few other interesting points from the 2019 report include:
- Managers underestimate the level of importance of analytics investors are using to evaluate them. For example, when considering quantitative due diligence, 68% of investors rated loss ratios as very or extremely important, while only 32% of fund managers rated loss ratios similarly (page 22).
- Forty-one percent of investors indicated they were very or extremely concerned with competition for deals, while only 25% of fund managers responded that they were very or extremely concerned about competition for deals (page 7).
- Thirty-eight percent of investors responded that they were very or extremely concerned about private company valuations while only 23% of fund managers said they were very or extremely concerned about valuations (page 7).
- The probability of a market correction was a top three concern for both fund managers and investors with close to two thirds of the view it was likely to occur within the next two years. (page 8).
- ESG has been a hot topic for several years but use of ESG in evaluating private markets fund managers is not very important to most investors and consultants. Only 16% of investors and consultants surveyed said ESG at the firm level was very important in their evaluation of private markets managers and only 6% said it was very important at the underlying deal level. (page 28).
The survey of institutional investors, consultants and private markets fund managers was conducted in early 2019. Investors and consultants responding to the survey represent more than $765 billion in assets under management/assets under administration (AUM/AUA) and aggregated private markets AUM/AUA of more than $131 billion. Private markets fund managers responding to the survey manage more than $600 billion.
To download a full copy of the report, please click here.
eVestment, a Nasdaq company, provides institutional investment data, analytics and market intelligence covering public and private markets. Asset managers and general partners reach the institutional marketplace through our platform, while institutional investors and consultants rely on eVestment for manager due diligence, selection and monitoring. eVestment brings transparency and efficiency to the global institutional market, equipping managers, investors and consultants to make data-driven decisions, deploy their resources more productively and ultimately realize better outcomes.
678 238 0761
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration23.8.2019 22:01:00 CEST | Press release
Foster City, Calif. and Mechelen, Belgium; 23 August 2019; 22.01 CET; regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced the closing of the global research and development collaboration agreement signed on 14 July 2019. This agreement has received clearance from the U.S. Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and merger control approval from the Austrian Federal Competition Authority. Under the terms of the agreement, the closing of this transaction triggers an upfront license fee payment of $3.95 billion by Gilead to Galapagos. In addition, Gilead has made an equity investment in Galapagos of approximately $1.1 billion (or approximately €960 million) by subscribing for new shares at a price of €140.59 per share, including issuance premium. As a result, Gilead now owns 13,589,686 ordinary shares of Galapagos, representing approximately 22 percent of the currently outsta
EVS Broadcast Equipment strikes major deal with NEP to upgrade their US production activities23.8.2019 18:00:00 CEST | Press release
Publication on August 23 2019, 06:00 P.M. CET Regulated information – Privileged information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS STRIKES MAJOR DEAL WITH NEP TO UPGRADE THEIR US PRODUCTION ACTIVITIES EVS Broadcast Equipment, the leading provider of live production solutions, today announces that NEP is investing over $8m to deploy the next generation EVS live video production server as part of their US inventory. Liège, Belgium, August 23, 2019 EVS, the leading provider of live production solutions, has been selected by NEP, an international production company serving live broadcasting throughout the world, to deliver a major upgrade and upscale of their production facilities. The deal represents the acquisition of EVS’ XT-VIA next-generation live production servers, as well as the deployment of LSM replay controllers, IPDirector content management solutions and other infrastructure systems. All new systems will be installe
Clinical data on Idorsia's pipeline compounds will be presented at the European Society of Cardiology Congress 201923.8.2019 17:35:00 CEST | Press release
Allschwil, Switzerland – August 23, 2019 Idorsia Ltd (SIX: IDIA) today announced that data from Phase 2 studies with aprocitentan, a new dual endothelin receptor antagonist, and selatogrel, a highly-selective P2Y12 receptor antagonist, will be shared during the European Society of Cardiology (ESC) Congress 2019 in Paris, France. Idorsia’s aprocitentan An oral presentation entitled "Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension", will be part of the "Drug treatment in hypertension - New insights" session with a focused discussion with the lead author, Dr Parisa Danaietash from Idorsia, at 09:54 on August 31, 2019. The abstract can be found online. Idorsia’s selatogrel An oral presentation entitled "Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients", will be part of th
Millicom - H1 2019 Consolidated Financial Statements23.8.2019 16:53:00 CEST | Press release
Millicom’s H1 2019 Consolidated Financial Statements Luxembourg, August 23, 2019— Millicom, a leading provider of cable and mobile services operating under the TIGO brand in Latin America, has published its H1 2019 consolidated financial statements. Contents include: • Management Report • Responsibility Statement • Review Report of the Independent Auditors • Unaudited Interim Condensed Consolidated Financial Statements -END- For further information, please contact Press: Vivian Kobeh, Corporate Communications Director +1 786-628-5300 email@example.com Investors: Michel Morin, VP Investor Relations +1 786-628-5270 firstname.lastname@example.org Sarah Inmon, Investor Relations Manager +1-786-628-5303 email@example.com About Millicom Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of cable and mobile services dedicated to emerging markets in Latin America and Africa. Millicom sets the pace when it comes to providing high-speed broadband and innovation around T
Banks net position in the Riksbank23.8.2019 16:42:00 CEST | Press release
AUG 23, 2019 SEK MILLION LENDING BORROWING 265
Conditions for Riksbank Bid Procedures Sek Bonds23.8.2019 16:20:00 CEST | Press release
Sveriges Riksbank Bid procedure details Government Bonds, 2019-08-29 Maturity date Loan ISIN code Coupon Volume, SEK million 2025-05-12 1058 SE0005676608 2.50 % 500 +/- 250 2039-03-30 1053 SE0002829192 3.50 % 500 +/- 250 Settlement date 2019-09-02 Bids have to be entered by 10.00 on AUG 29, 2019 Highest permitted bid volume: 500 SEK million in issue SGB 1058 and 500 SEK million in issue SGB 1053 Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CEST) ON AUG 29, 2019. For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se